Evelo Biosciences, Inc. Profile Avatar - Palmy Investing

Evelo Biosciences, Inc.

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase…

Biotechnology
US, Cambridge [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of EVLO's Analysis
CIK: 1694665 CUSIP: 299734103 ISIN: US2997342025 LEI: - UEI: -
Secondary Listings
EVLO has no secondary listings inside our databases.